Startup Media Story

News Archive

Magnets offer hope for people with sleep apnea

Magnets offer hope for people with sleep apnea February 16, 2017 Please read the original post by Tim Didion at abc7news.com SAN FRANCISCO (KGO) — For most of us, eight hours of sleep is rejuvenating. For others, it can be torture. “I would wake up multiple times a night, throwing up. I hadn’t been breathing for over a minute. And […]

Read more

How This AgTech Startup Is Giving Farmers Insight Into Their Soil’s Health

How This AgTech Startup Is Giving Farmers Insight Into Their Soil’s Health July 11, 2017 Please read the original post by Alex Knapp at forbes.com AgTech startup Trace Genomics began offering their custom soil health kit to farmers about a year ago. Their aim? To give their customers insights into how healthy their soil is. Its process is pretty simple […]

Read more

GraphWear presented SweatSmart beta at the NASDAQ

GraphWear presented SweatSmart beta at the NASDAQ GraphWear presented SweatSmart beta at the NASDAQ bell closing ceremony along with the CEO of the 49ers, Jed York and were featured on Times Square. This is the first time in human history that players would be able to extract their health information in real-time without blood pricks and they are excited to […]

Read more

David Seftel featured in San Francisco Chronicle

David Seftel featured in San Francisco Chronicle One of the great aspects of our community, are the wonderful people we work with.  Reading the front page of the Chronicle recently, we discovered that Dr. David Seftel is not only a co-founder of Enable Biosciences, but he also has a storied past of resisting Apartheid in South Africa and then becoming the […]

Read more

LogicInk – Is the future of wearable health tech ….TATTOOS?

Is the future of wearable health tech ….TATTOOS? A Talk at Techonomy On November 9th 2016, LogicInk gave their first public talk as a company at a conference called Techonomy in Half Moon Bay, CA. What happens when low-cost biosensors embedded in tattoos can detect blood alcohol, sugar, or biomarkers related to diseases like malaria or zika? How will that […]

Read more

Avant Completes Acquisitions of Amarantus, Theranostics Health

Avant Completes Acquisitions of Amarantus and Theranostics Health Avant Diagnostics announced today that it has completed its previously announced acquisitions of Amarantus Diagnostics and protein analysis services provider Theranostics Health. In January, Scottsdale, Arizona-based Avant inked a deal to merge with Amarantus Diagnostics, a subsidiary of therapeutics developer Amarantus Bioscience. The arrangement joins Amarantus’ research-use-only assays for multiple sclerosis and […]

Read more

ViewPoint Therapeutics Raises $4 Million in Series A Financing

ViewPoint Therapeutics Raises $4 Million in Series A Financing ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of a $4 million Series A financing. The transaction was co-led by Mission Bay Capital and Lagunita BioSciences LLC. Also included in the syndicate was healthcare-dedicated investor, […]

Read more

Miroculus Acquires Microfluidics Firm Kapplex

MicroRNA Diagnostics Developer Miroculus Acquires Microfluidics Firm Kapplex Miroculus, a San Francisco startup developing microRNA-based diagnostic tests, said Monday that it has acquired Toronto-based microfluidics firm Kapplex for an undisclosed amount. Miroculus emerged from stealth mode earlier this year at Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference. It aims to tap into the growing evidence that miRNAs can serve as useful […]

Read more

Dow AgroSciences and TeselaGen to collaborate

A new collaboration between Dow AgroSciences and TeselaGen Biotechnology Inc. is designed to produce a biological design automation platform that can speed up discovery work for new agricultural products. “TeselaGen has created a powerful suite of tools for DNA design,” said Daniel R. Kittle, Ph.D., vice president, research and development, Dow AgroSciences. “These tools have the potential to accelerate our […]

Read more

Perlstein Lab continues their rare disease drug discovery

Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they created helps the bio startup focus on finding cures for rare diseases rather than common ones. This novel approach is different from most Big Pharma labs and […]

Read more
Page 1 of 512345

Upcoming Event

  • Reaction before action: new approaches to biomineralization-associated diseases

    12:30-13:30
    10/19/2017
    Daniel Laser, PhD CEO and Co-Founder, Applaud Medical RSVP Applaud Medical is a three-year-old company developing treatments for biomineralization-related diseases. Applaud's products use violent physical effects like cavitation and shock waves to achieve a therapeutic effect, while sparing non-targeted tissue through precise chemical targeting. Applaud's lead product, for low-invasiveness treatment of kidney stones, is currently in clinical trials in Gujarat, India. This seminar will cover technical aspects of combining chemical reactions with mechanical action in both Applaud's products and in a range of other drugs and devices, along with a brief discussion of key commercialization considerations for this uniquely promising product category. About Daniel Laser Daniel Laser is Chief Executive Officer and co-founder of Applaud Medical. Dan also founded Wave 80 Biosciences, a pioneer in detecting HIV during the high-transmission-risk earliest phase of infection, when the immune response is insufficiently advanced for antibody-based methods. He has served as board member or advisor to drug and device companies in fields ranging from autoimmune disease to ophthalmology to cancer. Dan got his start in the medical device field working on haptic feedback for telerobotic surgery systems. Dan holds a Ph.D. in mechanical engineering from Stanford University, where he was a Semiconductor Research Corporation Graduate Fellow. While at Stanford, he was also a MacArthur Affiliate at Stanford’s Center for International Security and Cooperation, developing mathematical models for protecting against threats involving weaponized pathogens.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter